SHANGHAI, CHINA -- (MARKET WIRE) -- March 02, 2007 -- CDoor Corp. (“CDoor” or the “Company”) (OTCBB: CDCX) (which is now named “Sinobiomed Inc.”) is pleased to announce that on January 12, 2007, the Company completed a Share Purchase Agreement, dated December 21, 2006, entered into between the Company, Wanxin Bio-Technology Limited (“Wanxin”) and all the shareholders of Wanxin (the “Share Purchase Agreement”) whereby the Company acquired 100% of the issued and outstanding shares in the capital of Wanxin, through the issuance of 1,750,000 shares of our common stock in aggregate to the shareholders of Wanxin.
